statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Over the last three days, A.I.dvisor has detected that STIM's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Neuronetics (STIM, $4.84) Aroon Indicator entered an Uptrend on April 01, 2024.

William Blair reaffirmed their market perform rating on shares of Neuronetics (NASDAQ:STIM  Free Report) in a research note released on Tuesday morning, RTT News reports.
Separately, Piper...

Neuronetics (NASDAQ:STIM) Earns Market Perform Rating from William Blair

Neuronetics (STIM, $4.76) Aroon Indicator entered an Uptrend on March 28, 2024.

Neuronetics Inc (STIM) has shared an announcement. Neuronetics, Inc. is set to streamline its Board of Directors from eight to five members followi...

Neuronetics Inc Shrinks Board Following Strategy Review

MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that...

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

This price move could be a signal that STIM may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Neuronetics (STIM, $4.71) price may drop as it broke higher Bollinger Band on Mar 25, 2024

This is a signal that STIM's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Neuronetics (STIM, $4.71) RSI Indicator left the overbought zone on March 25, 2024

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and olderMALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a...

NeuroStar  Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

Neuronetics (STIM, $4.14) RSI Indicator left the overbought zone on March 08, 2024

Neuronetics (NASDAQ:STIM  Get Free Report)s stock had its overweight rating restated by equities researchers at Piper Sandler in a research note issued on Wednesday...

Neuronetics (NASDAQ:STIM) Rating Reiterated by Piper Sandler

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Watchers	2,474
52-Wk Low	$1.03
52-Wk High	$5.07

Volume	92,159.00
52-Wk High	$5.07
52-Wk Low	$1.03

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.27	--	--	N/A
Q1'24	-$0.31	-$0.27	12.78%	BEAT
Q4'23	-$0.26	-$0.19	26.75%	BEAT
Q3'23	-$0.31	-$0.33	-6.45%	MISSED
Q2'23	-$0.35	-$0.17	51.08%	BEAT

STIM Neuronetics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals